# Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension

> **NCT03254446** · PHASE3 · UNKNOWN · sponsor: **Torrent Pharmaceuticals Limited** · enrollment: 1250 (estimated)

## Conditions studied

- Diabetes
- Dyslipidemias
- Hypertension

## Interventions

- **DRUG:** TRC150094
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03254446
- **Lead sponsor:** Torrent Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-12
- **Primary completion:** 2022-04
- **Final completion:** 2022-08
- **Target enrollment:** 1250 (ESTIMATED)
- **Last updated:** 2020-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03254446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03254446, "Safety and Efficacy Study of TRC150094 to Improve the CV Risk in Subjects With Diabetes, Dyslipidemia and Hypertension". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03254446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*